Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 14,437 | 21,738 | 647 |
| Marketable Securities | N/A | 10,213 | 1,886 | N/A |
| Receivables | N/A | 1,635 | 164 | 82 |
| Other current assets | 0 | 556 | -1,860 | 53 |
| TOTAL | $N/A | $26,840 | $21,929 | $782 |
| Non-Current Assets | ||||
| PPE Net | N/A | 1,045 | 689 | 843 |
| TOTAL | $N/A | $1,045 | $689 | $843 |
| Total Assets | $N/A | $27,900 | $24,543 | $1,663 |
| Liabilities | ||||
| Current Liabilities | ||||
| TOTAL | $N/A | $1,703 | $1,367 | $1,891 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,703 | $1,367 | $2,048 |
| Shareholders' Equity | ||||
| Common Shares | N/A | 12 | 12 | N/A |
| Other shareholders' equity | 0 | 26,067 | 23,022 | -385 |
| TOTAL | $N/A | $26,079 | $23,034 | $-385 |
| Total Liabilities And Equity | $0 | $27,782 | $24,401 | $1,663 |